"Clinic of urology №1" LLC
Welcome,         Profile    Billing    Logout  
 0 Trials 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Galkina, Natalia
ATLAS, NCT04688931: A Phase 3 Study of UGN-102 for Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer

Recruiting
3
632
Europe, US, RoW
UGN-102, UGN-102 (mitomycin) for intravesical solution, TURBT, Transurethral resection of bladder tumors
UroGen Pharma Ltd.
Bladder Cancer, Urothelial Carcinoma, Urothelial Carcinoma Bladder
12/23
12/23

Download Options